MedTrace Logo

Right Ventricle Remodeling After Pulmonary Valve Replacement and Percutaneous Pulmonary Valve Insertion

NCT05090228 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 26

Last updated 2021-10-22

No results posted yet for this study

Summary

This study investigates damage of the right cardiac chamber in adult patients with a congenital heart defect involving the pulmonary valve (the heart valve between the right cardiac chamber and the lungs). The investigators want to investigate if novel, less invasive techniques are feasible to assess damage of this right cardiac chamber, to improve follow-up and timing of intervention (valve replacement) in this group of patients.

Conditions

  • Endomyocardial Fibrosis
  • Pulmonary Valve Stenosis
  • Pulmonary Valve Insufficiency

Sponsors & Collaborators

  • UMC Utrecht

    lead OTHER

Principal Investigators

  • Michiel Voskuil, MD, PhD · UMC Utrecht

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-02-01
Primary Completion
2020-06-01
Completion
2020-06-01

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05090228 on ClinicalTrials.gov